|Click on the figure to enlarge it.|
November 23, 2012
My initial post on this topic is here. Provectus made an 8-K filing today in which the company responded to the Levi & Korsinksy's PR regarding the law firm's so-called investigation into compensation provided to certain executive officers. See below.
Provectus: "On November 21, 2012, Provectus Pharmaceuticals, Inc., a Nevada corporation (the “Company”), was made aware, after the stock market closed, that the law firm of Levi & Korsinsky, LLP, is seeking information in connection with the compensation paid to the Company’s executive officers. The Company has received no inquiry from the staff of the U.S. Securities and Exchange Commission (the “SEC”) related to this matter. The Company has received no inquiry from Nasdaq or any other self-regulatory organization related to this matter. The Company has never received shareholder proposals related to compensation. The Company held its most recent annual meeting of stockholders on Thursday, June 28, 2012. The Company’s stockholders approved the advisory vote on the compensation of the Company’s named executive officers. The Company may take legal action to recoup expenses relating to this matter and to determine if stock manipulation, including possible shorting in the Company’s stock, has occurred due to the actions of Levi & Korsinsky."